Clinical Trials Browser

Phase 3 × Small Cell Lung Carcinoma × pembrolizumab × Clear all

NCT05224141 2025-07-08

KEYVIBE-008

Phase 3 Active not recruiting

460 enrolled 18 charts

Small Cell Lung Carcinoma

NCT04624204 2025-07-02

MK 7339-013

Phase 3 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Small Cell Lung Carcinoma

NCT03066778 2022-10-03

KEYNOTE-604

Phase 3 Completed

453 enrolled 23 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Small Cell Lung Carcinoma